For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260128:nRSb7656Qa&default-theme=true
RNS Number : 7656Q Bank of America Merrill Lynch 28 January 2026
FORM 8.3
IRISH TAKEOVER PANEL
OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH
TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1%
OR MORE
1. KEY INFORMATION
(a) Full name of discloser Bank of America Corporation
(b) Owner or controller of interests and short positions disclosed, if
different from 1(a)
The naming of nominee or vehicle companies is insufficient. For a trust, the
trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this AVADEL PHARMACEUTICALS PLC
form relates
Use a separate form for each offeror/offeree
(d) If an exempt fund manager connected with an offeror/offeree, state
this and specify identity of offeror/offeree (Note 1)
(e) Date position held/dealing undertaken 27/01/2026
For an opening position disclosure, state the latest practicable date prior to
the disclosure
(f) In addition to the company in 1(c) above, is the discloser also No
making disclosures in respect of any other party to the offer?
If it is a cash offer or possible cash offer, state "N/A"
2. INTERESTS AND SHORT POSITIONS
If there are interests and short positions to disclose in more than one class
of relevant securities of the offeror or offeree named in 1(c), copy table 2
for each additional class of relevant security.
Interests and short positions in the relevant securities of the offeror or
offeree to which the disclosure relates following the dealing (if any)
(Note 2)
Class of relevant security 0.01 ordinary shares
(Note 3)
Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled 520,309 0.534% 192,055 0.197%
(2) Cash-settled derivatives 136,043 0.140% 23,186 0.024%
(3) Stock-settled derivatives (including options) and agreements to 0 0.000% 0 0.000%
purchase/ sell
Total 656,352 0.674% 215,241 0.221%
All interests and all short positions should be disclosed.
Details of options including rights to subscribe for new securities and any
open stock-settled derivative positions (including traded options), or
agreements to purchase or sell relevant securities, should be given on a
Supplemental Form 8.
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE
DISCLOSURE (Note 4)
Where there have been dealings in more than one class of relevant securities
of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as
appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
Class of relevant Purchase/sale Number of Price per unit
security
securities (Note 5)
USD 0.01 common Purchase 440 21.56 USD
USD 0.01 common Purchase 855 21.57 USD
USD 0.01 common Purchase 267 21.58 USD
USD 0.01 common Purchase 2 21.585 USD
USD 0.01 common Purchase 35 21.59 USD
USD 0.01 common Purchase 315 21.54 USD
USD 0.01 common Purchase 18 21.55 USD
USD 0.01 common Purchase 17 21.565295 USD
USD 0.01 common Purchase 695 21.567008 USD
USD 0.01 common Purchase 1,426 21.5685 USD
USD 0.01 common Purchase 20 21.5705 USD
USD 0.01 common Purchase 18 21.570556 USD
USD 0.01 common Purchase 14 21.570715 USD
USD 0.01 common Purchase 20 21.5725 USD
USD 0.01 common Purchase 18 21.572778 USD
USD 0.01 common Purchase 14 21.572858 USD
USD 0.01 common Purchase 19 21.573685 USD
USD 0.01 common Purchase 20 21.574 USD
USD 0.01 common Purchase 15 21.574667 USD
USD 0.01 common Purchase 23 21.574783 USD
USD 0.01 common Purchase 618 21.575 USD
USD 0.01 common Purchase 107 21.575047 USD
USD 0.01 common Purchase 93 21.575054 USD
USD 0.01 common Purchase 29 21.575173 USD
USD 0.01 common Purchase 15 21.575334 USD
USD 0.01 common Purchase 22 21.57591 USD
USD 0.01 common Purchase 5 21.576 USD
USD 0.01 common Purchase 6 21.576667 USD
USD 0.01 common Purchase 23 21.577392 USD
USD 0.01 common Purchase 21 21.57762 USD
USD 0.01 common Purchase 18 21.577778 USD
USD 0.01 common Purchase 5 21.578 USD
USD 0.01 common Purchase 22 21.578182 USD
USD 0.01 common Purchase 40 21.5805 USD
USD 0.01 common Purchase 278 21.58331 USD
USD 0.01 common Purchase 9 21.585556 USD
USD 0.01 common Purchase 7 21.585715 USD
USD 0.01 common Purchase 1 21.54 USD
Class of relevant Purchase/sale Number of Price per unit
security
securities (Note 5)
USD 0.01 common Sale 1 21.54 USD
USD 0.01 common Sale 65 21.55 USD
USD 0.01 common Sale 218 21.57 USD
USD 0.01 common Sale 242 21.575 USD
USD 0.01 common Sale 177 21.58 USD
USD 0.01 common Sale 93 21.59 USD
USD 0.01 common Sale 3 21.57 USD
USD 0.01 common Sale 280 21.56 USD
USD 0.01 common Sale 8 21.565 USD
USD 0.01 common Sale 13 21.565385 USD
USD 0.01 common Sale 7 21.565715 USD
USD 0.01 common Sale 200 21.5725 USD
USD 0.01 common Sale 107 21.575047 USD
USD 0.01 common Sale 29 21.575173 USD
USD 0.01 common Sale 11 21.575455 USD
USD 0.01 common Sale 3 21.54 USD
USD 0.01 common Sale 4 21.565 USD
USD 0.01 common Sale 7 21.58 USD
(b) Cash-settled derivative transactions
Class of Product Nature of dealing Number of Price
relevant description e.g. opening/ closing a long/ short position, increasing/ reducing a long/ reference per unit
security e.g. CFD short position securities (Note 5)
(Note 6)
USD
USD 0.01 common Swaps Increasing a long position 1 21.54 USD
USD 0.01 common Swaps Increasing a short position 1,426 21.5687 USD
USD 0.01 common Swaps Increasing a short position 278 21.5835 USD
USD 0.01 common Swaps Reducing a short position 65 21.5498 USD
USD 0.01 common Swaps Increasing a short position 300 21.5402 USD
USD 0.01 common Swaps Reducing a short position 200 21.5723 USD
USD 0.01 common Swaps Increasing a short position 695 21.5672 USD
(c) Stock-settled derivative transactions (including
options)
(i) Writing, selling, purchasing or varying
Class of Product Writing, purchasing, selling, varying Number Exercise Type Expiry Option
relevant description e.g. call etc. of
price per e.g. date money
security option securities unit American,
paid/
to which European received per unit
option
etc.
relates
(Note 6)
N/A N/A N/A N/A N/A N/A N/A N/A
(ii) Exercise
Class of Product Exercising/ Number of Exercise
relevant description exercised securities price per
security e.g. call against unit
option (Note 5)
N/A N/A N/A N/A N/A
(d) Other dealings (including transactions in respect of
new securities) (Note 3)
Class of Nature of dealing Details Price per unit (if
relevant e.g. subscription, applicable)
security conversion, exercise (Note 5)
N/A N/A N/A N/A
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or
understanding, formal or informal, relating to relevant securities which may
be an inducement to deal or refrain from dealing entered into by the person
making the disclosure and any party to the offer or any person acting in
concert with a party to the offer.
Irrevocable commitments and letters of intent should not be included. If there
are no such agreements, arrangements or understandings, state "none"
(b) Agreements, arrangements or understandings relating to
options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
(c) Attachments
Is a Supplemental Form 8 attached? No
Date of disclosure 28/01/2026
Contact name Kamil Dziedzic
Telephone number +353 86 168 4821
Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory
Information Service.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END ITPFVLFLQFLEBBX
Copyright 2019 Regulatory News Service, all rights reserved